Skip to content

Ketogenic Feeding for Muscle Preservation After Trauma

Ketogenic Feeding to Preserve Muscle Mass in Middle-aged and Older Trauma Injury Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07827820
Acronym
KETO TRAUMA
Enrollment
20
Registered
2026-09-18
Start date
2026-11-15
Completion date
2029-08-31
Last updated
2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Injury

Keywords

ketogenic feeding, traumatic injury

Brief summary

The purpose of this study is to determine whether a ketogenic diet, provided as tube feeding, compared with a standard hospital tube feeding, is safe and feasible and helps preserve muscle mass and improve metabolic health in adults aged 55 years and older hospitalized with traumatic injury.

Interventions

The ketogenic feeding will have a macronutrient composition of approximately 10% energy from carbohydrates, 25% energy from protein, and 65% energy from fat.

The participants will receive standard hospital care feeding.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 55 years and older * Traumatic injury * Expected to survive and at least 10-day stay in the hospital * Expected to be enterally fed for at least 10 days * Willingness to be randomized to either treatment group * Willingness to participate in all study procedures

Exclusion criteria

* Failure to provide informed consent * Moribund * Vegeterian/vegan * Diagnosed dementia * Hip fracture, hip or knee replacement, or spinal surgery within past 4 months * Simultaneous participation in another intervention trial

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Adverse EventsAt baseline and 10-day of feedingNumber of adverse events collected using a standardized adverse event reporting form (Unit: Count of events).
Adherence to the InterventionFrom baseline to 10 days follow-up.Percentage of prescribed intervention sessions completed, assessed through adherence logs and system usage records (Unit: %)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 19, 2026